Free Trial

Burney Co. Sells 30,940 Shares of Genpact Limited $G

Genpact logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Burney Co. reduced its stake in Genpact by 15.3% in Q4, selling 30,940 shares and leaving 171,536 shares valued at $8.02 million, while institutional investors collectively own about 96.03% of the company.
  • Insiders have been net sellers — 33,904 shares sold in the past 90 days, including SVP Riju Vashisht (16,016 shares at $46.65) and CEO Balkrishan Kalra (2,800 shares at $40.77), leaving insiders with roughly 1.58% ownership.
  • Operationally, Genpact topped quarterly estimates (EPS $0.97 vs. $0.93; revenue $1.32B vs. $1.31B), raised its quarterly dividend to $0.1875 ($0.75 annualized, ~2.2% yield), but maintains a consensus analyst rating of Hold with an average price target of $47.29.
  • Interested in Genpact? Here are five stocks we like better.

Burney Co. decreased its stake in shares of Genpact Limited (NYSE:G - Free Report) by 15.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 171,536 shares of the business services provider's stock after selling 30,940 shares during the quarter. Burney Co. owned 0.10% of Genpact worth $8,024,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in G. Royal Bank of Canada increased its stake in Genpact by 19.7% in the first quarter. Royal Bank of Canada now owns 121,705 shares of the business services provider's stock valued at $6,131,000 after acquiring an additional 20,043 shares during the period. Amundi bought a new stake in Genpact in the first quarter valued at about $58,000. Goldman Sachs Group Inc. increased its stake in Genpact by 20.8% in the first quarter. Goldman Sachs Group Inc. now owns 353,074 shares of the business services provider's stock valued at $17,788,000 after acquiring an additional 60,887 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Genpact by 12.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 511,627 shares of the business services provider's stock valued at $25,776,000 after acquiring an additional 56,557 shares during the period. Finally, Focus Partners Wealth increased its stake in Genpact by 10.3% in the first quarter. Focus Partners Wealth now owns 5,227 shares of the business services provider's stock valued at $263,000 after acquiring an additional 488 shares during the period. Institutional investors own 96.03% of the company's stock.

Insiders Place Their Bets

In other Genpact news, SVP Riju Vashisht sold 16,016 shares of the company's stock in a transaction dated Tuesday, January 13th. The shares were sold at an average price of $46.65, for a total transaction of $747,146.40. Following the sale, the senior vice president directly owned 95,521 shares of the company's stock, valued at approximately $4,456,054.65. This represents a 14.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Balkrishan Kalra sold 2,800 shares of the company's stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $40.77, for a total transaction of $114,156.00. Following the sale, the chief executive officer directly owned 525,007 shares in the company, valued at $21,404,535.39. This represents a 0.53% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 33,904 shares of company stock valued at $1,565,158. 1.58% of the stock is currently owned by insiders.

Analyst Ratings Changes

G has been the topic of a number of analyst reports. Needham & Company LLC lowered their target price on shares of Genpact from $53.00 to $50.00 and set a "buy" rating on the stock in a research note on Friday, February 6th. Susquehanna set a $42.00 target price on shares of Genpact in a research note on Friday, February 6th. Wall Street Zen cut shares of Genpact from a "buy" rating to a "hold" rating in a research note on Saturday, March 14th. Citigroup raised shares of Genpact from a "hold" rating to a "strong-buy" rating in a research note on Friday, February 13th. Finally, Mizuho lowered their target price on shares of Genpact from $51.00 to $49.00 and set a "neutral" rating on the stock in a research note on Tuesday, February 10th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and six have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Genpact has a consensus rating of "Hold" and an average price target of $47.29.

Read Our Latest Analysis on Genpact

Genpact Price Performance

Shares of Genpact stock opened at $34.19 on Friday. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.46. The stock has a market capitalization of $5.80 billion, a price-to-earnings ratio of 10.92, a P/E/G ratio of 1.01 and a beta of 0.74. Genpact Limited has a 1-year low of $33.92 and a 1-year high of $50.41. The firm's 50-day moving average price is $38.43 and its two-hundred day moving average price is $42.01.

Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings data on Friday, February 6th. The business services provider reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.04. The firm had revenue of $1.32 billion for the quarter, compared to analysts' expectations of $1.31 billion. Genpact had a net margin of 10.88% and a return on equity of 22.02%. The company's quarterly revenue was up 5.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.91 earnings per share. On average, equities analysts predict that Genpact Limited will post 3.21 earnings per share for the current fiscal year.

Genpact Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Shareholders of record on Monday, March 16th were paid a dividend of $0.1875 per share. This is a positive change from Genpact's previous quarterly dividend of $0.17. This represents a $0.75 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend was Monday, March 16th. Genpact's payout ratio is currently 23.96%.

Genpact Profile

(Free Report)

Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.

Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.

Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific.

See Also

Institutional Ownership by Quarter for Genpact (NYSE:G)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2026 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines